Table 1.
Primary Sites/Histologies for Which Screening Imaging of the Brain Is Recommended vs Not per the National Comprehensive Cancer Network
| Screening Recommendeda | No Routine Screening Recommended |
|---|---|
| Lung (non–small cell lung cancer) | Breast |
| Lung (small cell lung cancer)b | Bladder |
| Melanoma (non-uveal) | Gastrointestinal |
| Sarcoma (alveolar soft parts sarcoma/angiosarcoma/left-sided cardiac sarcoma) | Gynecologic |
| Testicularc | Head/neck |
| Hepatobiliary | |
| Melanoma (uveal) | |
| Pancreatic | |
| Prostate | |
| Renal | |
| Sarcoma (other than alveolar soft parts sarcoma/angiosarcoa/left-sided cardiac sarcoma) | |
| Thymic | |
| Thyroid |
aRecommendation varies by stage.
bIncludes small cell/neuroendocrine histologies of other primary sites.
cIf indicated based on histology, extent of disease, tumor markers, and/or symptoms.